E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy

• Simone Claudiani,
• Jane F. Apperley,
• Robert Peter Gale,
• Richard Clark,
• Richard Szydlo,
• Simona Deplano,
• Renuka Palanicawandar,
• Jamshid Khorashad,
• Letizia Foroni,
• Dragana Milojkovic

Affiliations

Simone Claudiani

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Jane F. Apperley

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Robert Peter Gale

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Richard Clark

Royal Liverpool University Hospital, UK

Richard Szydlo

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Simona Deplano

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Renuka Palanicawandar

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Jamshid Khorashad

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Letizia Foroni

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Dragana Milojkovic

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London